Advertisement
Legal
Subscribe to Legal

The Lead

Obama Wants Limits on US Company Mergers Abroad

July 25, 2014 8:32 am | News | Comments

Staking out a populist stand ahead of the midterm elections, President Barack Obama on Thursday demanded "economic patriotism" from U.S. corporations that use legal means to avoid U.S. taxes through overseas mergers.      

When Will We Learn?

July 23, 2014 3:11 pm | by Mike Auerbach, Editor In Chief | Blogs | Comments

Humans are a strange lot. We are more than willing to believe just about any product claim in...

States Sue 5-Hour Energy Over Ad Claims

July 21, 2014 8:35 am | by STEVEN DUBOIS, Associated Press | News | Comments

The Oregon lawsuit filed Thursday in Portland contends 5-Hour Energy falsely claims customers...

China Indicts US, British Nationals Involved In GSK Investigation

July 13, 2014 11:26 pm | by The Associated Press | News | Comments

Chinese authorities formally indicted two corporate investigators, an American and Briton, for...

View Sample

FREE Email Newsletter

Compounding Pharmacy Oversight Changes Signed

July 11, 2014 8:22 am | News | Comments

Two years after a deadly nationwide meningitis outbreak linked to a compounding pharmacy in Massachusetts, Gov. Deval Patrick on Thursday signed a law he said would address a "gray area" between state and federal oversight of the pharmacies.  

Neurelis Regains Rights to Intranasal Diazepam Program

July 11, 2014 8:08 am | News | Comments

Neurelis has announced an agreement with Biotie Therapies to end the option held by Biotie to purchase Neurelis, clearing the way for Neurelis to commence further development of NRL-1 for pediatric and adult epilepsy patients who experience acute repetitive seizures.

Hospital Pharmacist Charged in Theft of 200K Pills

July 9, 2014 8:19 am | by JENNIFER PELTZ, Associated Press | News | Comments

A pharmacist who oversaw a major hospital's vault of drugs stole nearly 200,000 powerful painkillers he was supposed to safeguard and dispense, narcotics prosecutors said Tuesday as they unveiled a case that makes unusual use of a state drug-kingpin law.

Advertisement

$580M EU Antitrust Fine for Drug Makers

July 9, 2014 8:14 am | News | Comments

The European Union's antitrust body is imposing a fine of 428 million euros ($580 million) on France's pharmaceutical company Servier and five producers of generic medicines for distorting competition.        

US Officials Barred from American's Trial in China

July 4, 2014 5:25 am | by The Associated Press | News | Comments

A U.S. Embassy spokesman says diplomats are barred from the trial in Shanghai of an American investigator for GlaxoSmithKline and her British husband who are charged with improperly selling personal information. Spokesman Nolan Barkhouse said Friday that the U.S. government is concerned about lack of access to the trial of Yu Yingzeng and husband Peter Humphrey in August.

AIDS Scientist Pleads Not Guilty to Faking Study

July 2, 2014 8:22 am | by DAVID PITT, Associated Press | News | Comments

Dong-Pyou Han, 57, entered his not guilty pleas to four counts of making false statements during his initial court appearance in Des Moines federal court. Each count carries a maximum sentence of five years in prison and a $250,000 fine.  

Justices: Can't Make Employers Cover Contraception

June 30, 2014 2:08 pm | by MARK SHERMAN, Associated Press | News | Comments

The Supreme Court ruled Monday that some corporations can hold religious objections that allow them to opt out of the new health law requirement that they cover contraceptives for women. The justices' 5-4 decision is the first time that the high court has ruled that profit-seeking businesses can hold religious views under federal law.

High Court Poised to Decide Birth-Control Dispute

June 30, 2014 8:17 am | by MARK SHERMAN, Associated Press | News | Comments

The Supreme Court is poised to deliver its verdict in a case that weighs the religious rights of employers and the right of women to the birth control of their choice. The court meets for a final time Monday to release decisions in its two remaining cases before the justices take off for the summer.

Advertisement

Actavis Confirms Generic Zubsolv Patent Challenge

June 30, 2014 8:00 am | News | Comments

Actavis' ANDA product is a generic version of Orexo's Zubsolv, which is a partial opioid agonist indicated for the maintenance treatment of opioid dependence.               

Pershing Square Settles Lawsuit with Allergan

June 27, 2014 3:28 pm | by The Associated Press | News | Comments

Pershing Square, the investment firm run by activist investor Bill Ackman, said Friday it settled a lawsuit with Allergan, the maker of Botox, related to Allergan's poison pill plan and Pershing's $53 billion offer for the company.   

Can Shareholders Stop a Company From Going Global?

June 27, 2014 8:53 am | Videos | Comments

A group of shareholders, led by Yujiro Hara, opposes the hiring of foreign executives at Takeda Pharmaceutical, the biggest drug company in Japan, calling it a “hijacking by foreign capital.”          

Kentucky Oncology Practice and Manager Plead Guilty to Purchasing and Selling Unapproved Chemotherapy Drugs

June 27, 2014 7:55 am | News | Comments

Hematology and Oncology Center (HOC) PLLC of Somerset, Kentucky has pleaded guilty to federal charges that the firm purchased and sold unapproved and improperly labeled chemotherapy drugs. HOC’s former office manager, Natarajan Murugesan, also pleaded guilty to assisting with these activities.

Drug Company Lawsuit Defense Out of NC Senate Bill

June 26, 2014 8:13 am | News | Comments

A House panel Wednesday deleted language from a Senate bill that previously would have made it harder for people to sue pharmaceutical companies over products if they met federal regulations and warned of side effects.      

Advertisement

Europe Euthanasia Rulings Spark Debate

June 25, 2014 8:35 am | by LORI HINNANT, Associated Press | News | Comments

A French doctor was acquitted Wednesday of poisoning charges after giving lethal injections to seven terminally ill patients, and Britain's Supreme Court said an assisted-suicide ban is incompatible with human rights, fueling the arguments of those who say the duty of doctors is to end the suffering of those beyond treatment.

Researcher Charged in Major HIV Vaccine Fraud Case

June 25, 2014 8:29 am | by RYAN J. FOLEY, Associated Press | News | Comments

Responding to a major case of research misconduct, federal prosecutors have taken the rare step of filing charges against a scientist after he admitted falsifying data that led to millions in grants and hopes of a breakthrough in AIDS vaccine research.

Ackman Seeks Allergan 'Poison Pill' End Run

June 13, 2014 8:14 am | News | Comments

Bill Ackman's Pershing Square Capital Management, seeking legal cover in its $53 billion takeover bid for Allergan, filed a lawsuit to confirm that its push for a special meeting of shareholders won't trigger a defensive "poison pill" plan from the Botox maker.

Court Rules for Pom Wonderful in Dispute with Coke

June 13, 2014 8:06 am | by SAM HANANEL, Associated Press | News | Comments

The Supreme Court on Thursday sided with juice maker Pom Wonderful in its long-running false advertising dispute with the Coca-Cola Co., a decision that could open the door to more litigation against food makers for deceptive labeling.   

VIVUS Files Lawsuit Against Actavis for Infringement of Qsymia Patents

June 13, 2014 8:00 am | News | Comments

The lawsuit was filed in response to an Abbreviated New Drug Application, or ANDA, filed by Actavis. In its application, Actavis seeks to market and sell generic versions of the currently approved doses of Qsymia®      

U.S. Court of Appeals Denies Appeal in Baraclude Patent Case

June 13, 2014 7:47 am | News | Comments

Bristol-Myers Squibb Company has announced that the U.S. Court of Appeals for the Federal Circuit has denied the company’s appeal of a February 2013 ruling by the U.S. District Court for the District of Delaware that found the patent covering Baraclude (entecavir), U.S. patent 5,206,244 invalid.

Ex-Novartis Pharma Employee Arrested Over Drug Data

June 11, 2014 8:19 am | News | Comments

Tokyo prosecutors arrested a former employee of Novartis Pharma K.K. on Wednesday on a charge of manipulating clinical study data leading to exaggerated claims in advertising for one of the firm's drugs.        

Actavis Finalizes Agreement Related to Asacol HD Patent Challenge Litigation

June 10, 2014 8:25 am | News | Comments

Actavis has finalized its previously announced agreement with Zydus Pharmaceuticals USA Inc. to settle all outstanding patent litigation related to Zydus' generic version of Asacol HD (mesalamine) delayed-release tablets.     

NJ Court Rules for Nurse in Vaccine-Refusal Firing

June 5, 2014 3:38 pm | News | Comments

A New Jersey appeals court says a nurse was unfairly denied unemployment benefits after she was fired for refusing a flu shot.                     

$100M NuvaRing Settlement Finalized

June 5, 2014 3:33 pm | by JIM SALTER, Associated Press | News | Comments

A $100 million settlement involving NuvaRing, a birth-control device linked to sometimes-fatal side effects, will stand now that the vast majority of claimants have chosen to opt into the agreement, those involved in the lawsuits said Thursday.

Senate Moves Toward Vote on VA Health Care

June 5, 2014 8:22 am | by MATTHEW DALY, Associated Press | News | Comments

The Senate is moving forward on a compromise bill to help veterans avoid long waits to see a doctor and make it easier to fire administrators who falsify records to cover up long wait times.          

GlaxoSmithKline Agrees to $105M Settlement

June 4, 2014 6:32 pm | by The Associated Press | News | Comments

GlaxoSmithKline PLC will pay $105 million to dozens of states to settle allegations that it marketed drugs for uses unapproved by federal regulators. Lawsuits filed in 44 states and the District of Columbia alleged that the British drugmaker misrepresented the uses and qualities of its asthma drug Advair and the antidepressants Paxil and Wellbutrin.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading